Get started
Author

Maria Rosaria De Filippo

Observed names: De Filippo M. R., De Filippo, Maria Rosaria, M R De Filippo, M.R. De Filippo, Maria R De Filippo, Maria R. De Filippo, Maria R. Filippo, Maria Rosaria de Filippo
Observed institutions: University of Bern, University of Salerno, Memorial Sloan Kettering Cancer Center, Suzuki (Japan), Universitat de Lleida, University of Basel, University of Campania "Luigi Vanvitelli", Hospital Universitari Arnau de Vilanova, University Hospital of Basel, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Federico II University Hospital, IRCCS Ospedale San Raffaele, Hospital Universitario Ramón y Cajal, IRCCS San Raffaele Roma, University of Naples Federico II
ORCID: 0000-0001-8350-2599
Observed ORCID: 0000-0001-8350-2599
OpenAlex ID: A5062018914
Genomic characterization of metastatic breast cancers
2019 · François Bertucci, Charlotte K. Y. Ng, et al. · Nature · 720
Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
2015 · Anne M. Schultheis, Charlotte K. Y. Ng, et al. · JNCI Journal of the National Cancer Institute · 259
PDF
MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates
2018 · Thomas Andreas Kohl, Christian Utpatel, et al. · PeerJ · 235
Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation
2011 · Oli MV Grober, Margherita Mutarelli, et al. · BMC Genomics · 176
PDF
Patient-derived xenografts and organoids model therapy response in prostate cancer
2021 · Sofia Karkampouna, Federico La Manna, et al. · Nature Communications · 168
PDF
Genomic landscape of adenoid cystic carcinoma of the breast
2015 · Luciano G Martelotto, Maria R De Filippo, et al. · The Journal of Pathology · 157
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity
2020 · Joanna Cyrta, Anke Augspach, et al. · Nature Communications · 153
PDF
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers
2015 · Anne M. Schultheis, Luciano G. Martelotto, et al. · International Journal of Gynecological Pathology · 134
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations
2014 · Luciano G Martelotto, Charlotte Ng, et al. · Genome biology · 134
PDF
Uterine adenosarcomas are mesenchymal neoplasms
2015 · Salvatore Piscuoglio, Kathleen A Burke, et al. · The Journal of Pathology · 125
PDF
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
2016 · Paul S Weisman, Charlotte K Y Ng, et al. · Modern Pathology · 115
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer
2012 · O Paris, L Ferraro, et al. · Oncogene · 101
PDF
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
2016 · Nicola Fusco, Felipe C Geyer, et al. · Modern Pathology · 85
PDF
The genetic landscape of breast carcinomas with neuroendocrine differentiation
2016 · Caterina Marchiò, Felipe C Geyer, et al. · The Journal of Pathology · 78
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study
2015 · Elena Guerini‐Rocco, Zsolt Hodi, et al. · The Journal of Pathology · 71
PDF
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
2016 · Elena Guerini‐Rocco, Salvatore Piscuoglio, et al. · The Journal of Pathology · 65
iMir: An integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq
2013 · Giorgio Giurato, Maria Rosaria De Filippo, et al. · BMC Bioinformatics · 63
PDF
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells
2012 · Lorenzo Ferraro, Maria Ravo, et al. · Hormones and Cancer · 59
PDF
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey
2017 · Elisa Tagliani, Mohamed Osman Hassan, et al. · Scientific Reports · 43
PDF
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
2018 · Leticia De Mattos-Arruda, Charlotte K. Y. Ng, et al. · Oncotarget · 41
PDF
Lack of pathogenic mutations in six patients with MMPSI
2013 · Maria Rosaria De Filippo, Francesca Rizzo, et al. · Epilepsy Research · 41
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries
2018 · Andrea Maurizio Cabibbe, Alberto Trovato, et al. · European Respiratory Journal · 40
PDF
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
2020 · Federico La Manna, Marta De Menna, et al. · Frontiers in Oncology · 38
PDF
Molecular Mechanisms of Selective Estrogen Receptor Modulator Activity in Human Breast Cancer Cells: Identification of Novel Nuclear Cofactors of Antiestrogen–ERα Complexes by Interaction Proteomics
2012 · Francesca Cirillo, Giovanni Nassa, et al. · Journal of Proteome Research · 37
Post-transcriptional Regulation of Human Breast Cancer Cell Proteome by Unliganded Estrogen Receptor β via microRNAs
2014 · Giovanni Nassa, Roberta Tarallo, et al. · Molecular & Cellular Proteomics · 34
PDF
Works count: 63
Citation count: 3,396
H-index: 27
I10-index: 34
Year
Topic
Type